Research shows bimagrumab may prevent muscle and bone loss associated with weight loss medications like Wegovy, offering hope ...
A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...
A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...
ACCP Position Statement: "Ensuring the Appropriate Use of Glucagon-Like Peptide-1 Receptor Agonists"
The two main incretins involved in this process are glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Currently, there are two approved GLP-1 and one combined ...
Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...
Health experts say popular weight-loss drugs like Ozempic and Wegovy are safe, but the FDA warns counterfeits are becoming more widespread.
8d
GlobalData on MSNSuper Bowl ad for copycat weight loss drugs stokes pharma power debateControversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...
7d
GlobalData on MSNEli Lilly pledges $630m on OliX’s Phase I RNA candidate for MASHEli Lilly is paying up to $630m for a Phase I MASH candidate from OliX Pharmaceuticals, diversifying its pipeline with an RNA ...
While widely known for its male health offerings, Ro has more recently added glucagon-like peptide-1 ... and help the body process sugars, with 1 year of coaching. Ro’s health coaches can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results